Affinity Asset Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.4M | Sell |
|
|||||
|
2025
Q1 | $44.6M | Buy |
|
|||||
|
2024
Q4 | $45.5M | Buy |
|
|||||
|
2024
Q3 | $45M | Buy |
|
|||||
|
2024
Q2 | $38.8M | Buy |
|
|||||
|
2024
Q1 | $36M | Buy |
|
|||||
|
2023
Q4 | $21.2M | Buy |
|
|||||
|
2023
Q3 | $10.3M | Buy |
|
|||||
|
2023
Q2 | $2.32M | Sell |
|
|||||
|
2023
Q1 | $3.22M | Buy |
|
|||||
|
2022
Q4 | $1.97M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $2.45M | Sell |
|
|||||
|
2021
Q4 | $4.7M | Buy |
|
|||||
|
2021
Q3 | $764K | Buy |
|